NCT03360292

Brief Summary

The investigators aim to measure the effect of targeting premature babies to a slightly higher oxygen saturation target range (92-97%) than routinely used, for a brief period, to plan a future larger study of the effect of this on clinical outcomes. It is still unclear exactly what levels of oxygen premature babies need - both too little or too much oxygen in the first weeks after birth may be harmful. Previous studies used saturation monitoring (SpO2), where a small probe shines light through the skin and calculates how much oxygen is carried in the blood. These studies demonstrated using an SpO2 range of 91-95% rather than 85-89% was associated with more babies surviving and fewer babies suffering from a bowel condition called necrotising enterocolitis (NEC). However, targeting oxygen higher increased the number of infants who needed treatment for an eye condition called retinopathy of prematurity (ROP). It is possible an SpO2 range higher than 91-95% would be associated with even better survival. It is also possible that a higher range might not improve survival but could increase the need for ROP treatment. Infants born at less than 29 weeks gestation, greater than 48 hours of age and receiving supplementary oxygen would be eligible for inclusion. The study is at the Royal Infirmary of Edinburgh. Total study time is 12 hours for each infant (6 hours at the standard 90-95% range used in our unit, and 6 hours at 92-97%). It is a crossover study with infants acting as their own controls. Based on previous research the investigators are confident these oxygen levels will not be dangerously high. To provide an additional measure of oxygen the investigators will also use a transcutaneous monitor for the 12 hour study period, which fastens gently to the skin and measures oxygen and carbon dioxide levels on the skin surface.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jan 2020

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 27, 2017

Completed
7 days until next milestone

First Posted

Study publicly available on registry

December 4, 2017

Completed
2.1 years until next milestone

Study Start

First participant enrolled

January 18, 2020

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 18, 2021

Completed
9 months until next milestone

Study Completion

Last participant's last visit for all outcomes

February 17, 2022

Completed
Last Updated

March 28, 2022

Status Verified

September 1, 2019

Enrollment Period

1.3 years

First QC Date

November 27, 2017

Last Update Submit

March 10, 2022

Conditions

Keywords

Neonatology

Outcome Measures

Primary Outcomes (1)

  • Incidence of hyperoxia and hypoxia on saturations

    Percentage time spent above an SpO2 of 97% and below an SpO2 of 90% when infants are targeted to an SpO2 range of 92-97% compared to 90-95%

    12 hours

Secondary Outcomes (6)

  • Incidence of hyperoxia and hypoxia on Transcutaneous monitoring

    12 hours

  • Saturation variability

    12 hours

  • Transcutaneous variability

    12 hours

  • Characterise PaO2 values within the two oxygen saturation target ranges

    12 hours

  • Pooled frequency histogram of SpO2

    12 hours

  • +1 more secondary outcomes

Study Arms (2)

Higher target range

EXPERIMENTAL

Infants will be targeted to 92-97% oxygen saturation

Other: Higher target range

Standard target range

NO INTERVENTION

Infants will be targeted to 90-95% oxygen saturation, which is the range used as routine in the Neonatal Unit involved in the study

Interventions

Intervention is using a higher oxygen saturation target range than in routine practice

Also known as: Using a higher oxygen saturation target range
Higher target range

Eligibility Criteria

Age48 Hours - 1 Month
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Infants born at less than 29 weeks gestation
  • Infants greater than 48 hours of age
  • Infants who are receiving supplementary oxygen

You may not qualify if:

  • Congenital anomalies that would affect oxygenation (eg. cardiac defects, congenital diaphragmatic hernia)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Neonatal Unit - Royal Infirmary of Edinburgh

Edinburgh, Lothian, EH16 4SA, United Kingdom

Location

Related Publications (1)

  • Christie FG, Kelly R, Boardman JP, Stenson BJ. Measuring Oxygenation in Newborn Infants with Targeted Oxygen Ranges (MONITOR): a randomised crossover pilot study. Arch Dis Child Fetal Neonatal Ed. 2023 Nov;108(6):638-642. doi: 10.1136/archdischild-2022-324833. Epub 2023 May 4.

MeSH Terms

Conditions

Premature BirthHypoxiaHyperoxia

Condition Hierarchy (Ancestors)

Obstetric Labor, PrematureObstetric Labor ComplicationsPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesSigns and Symptoms, RespiratorySigns and SymptomsPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Masking Details
Infants will be randomised to either higher (92-97%) or lower (90-95%) oxygen saturation target range, and then cross-over to the alternative range after 6 hours of monitoring (with 12 hours in total study time). The study is randomised but not blinded.
Purpose
TREATMENT
Intervention Model
CROSSOVER
Model Details: This is a randomised cross-over study of oxygen target ranges in premature infants, with infants acting as their own controls.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 27, 2017

First Posted

December 4, 2017

Study Start

January 18, 2020

Primary Completion

May 18, 2021

Study Completion

February 17, 2022

Last Updated

March 28, 2022

Record last verified: 2019-09

Data Sharing

IPD Sharing
Will not share

Locations